GW 0742

GW 0742 for Sale | 3rd-Party Tested Pure | Purerawz PPARβ/δ Agonist Research Compound

What is GW 0742?

Within the expanding field of metabolic research, PPARβ/δ agonists have emerged as one of the most scientifically compelling compound classes for studying fat oxidation, insulin sensitivity, and glucose homeostasis in experimental models. GW 0742 represents the most advanced research tool in this category.

GW 0742 is a potent synthetic PPARβ/δ (Peroxisome Proliferator-Activated Receptor beta/delta) agonist that has attracted significant scientific attention for its possible role in metabolic regulation, inflammation control, and cardiovascular function in preclinical research models. Often referenced in scientific literature as a structurally advanced analog of Cardarine (GW501516), GW 0742 shares the same receptor target family while offering a distinct fluorinated molecular profile that differentiates its research characteristics. Originally developed by GlaxoSmithKline, GW 0742 has since become a widely studied research compound across metabolism, diabetes, hypertension, and inflammatory biology research disciplines. All products on Purerawzus.com are strictly intended for laboratory and research use only and are not approved by the FDA for human or veterinary use.

GW 0742 Chemical Properties

Property	Details
CAS Number	317318-84-6
Molar Mass	471.48 g/mol
Chemical Formula	C21H17F4NO3S2
IUPAC Name	2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid
Classification	PPARβ/δ Receptor Agonist
Developer	Originally developed by GlaxoSmithKline
Research Use	Laboratory and Scientific Research Only
Regulatory Status	Not approved by the FDA for human or veterinary use

How Does GW 0742 Work?

Scientific investigation has identified several interconnected mechanisms through which GW 0742 may exert its metabolic and biological effects in preclinical research models:

Potential Mechanism	Research Context
PPARβ/δ Receptor Activation	Primarily activates PPARβ/δ nuclear receptors involved in metabolic regulation
Fatty Acid Oxidation Stimulation	May stimulate the utilization of fat as fuel increasing oxidative metabolism
AMPK Activity Enhancement	Studies suggest possible increases in AMPK activity linked to metabolic regulation
Androgen Receptor Antagonism	Demonstrates weak antagonism of androgen receptors in research settings
Vitamin D Receptor Interaction	Has shown interaction with vitamin D receptors in preclinical research models
Thyroid Hormone Receptor Effects	Has demonstrated effects on thyroid hormone receptors in laboratory studies
Glucose Homeostasis Support	May improve glucose uptake through PPAR-δ activation in diabetic research models

GW 0742 vs Cardarine Research Comparison

Understanding the distinction between GW 0742 and Cardarine is essential for researchers selecting the most appropriate PPARβ/δ compound for their specific study requirements:

Feature	GW 0742	Cardarine (GW501516)
Receptor Target	PPARβ/δ agonist	PPARβ/δ agonist
Developer	GlaxoSmithKline	GlaxoSmithKline
Molecular Structure	Two hydrogen and four fluorine atoms	One hydrogen and three fluorine atoms
Classification	Fluorinated Cardarine analog	Parent PPARβ/δ compound
Insulin Resistance Research	Studied in diabetic and obese research models	Studied in metabolic research models
Fatty Acid Oxidation Research	Being investigated in preclinical models	Established research applications

Potential Benefits of GW 0742 in Research

Animal and cell-based scientific investigation has highlighted several areas where GW 0742 may offer significant preclinical research value:

Potential Benefit	Research Context
Metabolic Research	Studies suggest possible diet-induced weight loss and visceral fat reduction in research models
Insulin Sensitivity Research	Being studied for its possible role in improving insulin sensitivity in diabetic research models
Fat Oxidation Research	May stimulate fatty acid oxidation and fat utilization in metabolic research settings
Glucose Homeostasis Research	Studies suggest possible improvement of glucose uptake in diabetic animal models
Anti-Inflammatory Research	Being explored for its possible role in reducing inflammatory markers in research models
Hypertension Research	Animal studies suggest possible blood pressure reduction in hypertensive research models
Muscle Oxidative Capacity Research	May increase skeletal muscle oxidative capacity in exercise and obesity research models
Diabetes Research	Being investigated as a possible PPAR-δ targeted approach in diabetes research models

Please note: All benefits listed are based on animal and cell-based preclinical research. Human clinical research on GW 0742 remains limited. This product is strictly intended for research purposes only.

Potential Research Areas of GW 0742

Research Area	Potential Focus
Metabolic Regulation Research	Studying PPARβ/δ activation and its effects on fat oxidation and metabolic function
Insulin Resistance Research	Investigating its possible role in improving insulin sensitivity in diabetic research models
Obesity and Fat Loss Research	Exploring its possible influence on visceral fat reduction and weight management mechanisms
Glucose Homeostasis Research	Studying PPAR-δ mediated glucose uptake improvements in diabetic animal research
Anti-Inflammatory Research	Investigating its possible role in reducing inflammatory and apoptotic markers
Hypertension Research	Exploring PPARβ as a research target for blood pressure regulation in research models
Exercise Metabolism Research	Studying its possible influence on immune-metabolic changes induced by exercise
Cardiovascular Research	Investigating its possible cardioprotective applications in preclinical research settings
Diabetes Research	Exploring PPAR-δ targeted approaches for anti-diabetic mechanism research
Skeletal Muscle Research	Studying its possible effects on skeletal muscle inflammation and oxidative capacity

GW 0742 Research Findings

Metabolism and Fat Oxidation Research

A preclinical study investigating the effects of PPARβ/δ agonist treatment on immune-metabolic changes in diet-induced obese mice demonstrated increased fatty acid oxidation gene expression and elevated AMPK activity. Associated findings included reduced visceral adipose tissue mass, decreased skeletal muscle inflammation, and improved skeletal muscle oxidative capacity and insulin sensitivity in research subjects.

Insulin Resistance Research

GW 0742 has been studied for its possible ability to address metabolic abnormalities including insulin resistance in skeletal muscle tissue in mice maintained on high-fructose corn syrup diets. While promising results have been observed in these models the broader influence of GW 0742 on systemic insulin sensitivity continues to be investigated.

Inflammation Research

A dedicated preclinical investigation into GW 0742’s effects on inflammatory pathways found that this PPARβ/δ agonist reduced several inflammatory and apoptotic parameters in research models. Studies demonstrated possible reduction of lung inflammation induced by bleomycin exposure in mouse research subjects.

Diabetes Research

Animal-based research has suggested that GW 0742 may improve glucose homeostasis in diabetic research models through PPAR-δ activation pathways. These findings have led researchers to propose PPAR-δ as a potentially valuable target for future anti-diabetic mechanism research and investigation.

Hypertension Research

A 2011 preclinical study investigated whether GW 0742 might demonstrate anti-hypertensive effects in spontaneously hypertensive rat research models. Results suggested a progressive reduction in systolic arterial blood pressure and heart rate, leading researchers to propose PPARβ as a new target of interest in hypertension mechanism research.

Where to Buy GW 0742 Online

Purerawzus.com supplies COA-verified, high-purity research compounds with fast USA shipping on every order. Every purchase is backed by an independent Certificate of Analysis confirming compound identity, purity, and concentration for complete research compliance and documentation transparency. We offer multiple secure payment options including cryptocurrency and traditional payment methods to make your ordering experience seamless. Visit our how to pay page for a complete step by step guide to all available payment methods and secure checkout instructions.

Feature	Details
Testing	Independent third-party lab tested
Documentation	Certificate of Analysis (COA) included with every order
Shipping	Free international shipping on orders over $100
Payment Options	Multiple secure payment methods available
Support	24/7 expert customer support

Is GW 0742 Legal?

GW 0742 is legal to purchase and sell as a research chemical in applicable regions. This designation restricts its use strictly to scientific and research purposes only. Researchers must ensure full compliance with all applicable local laws and institutional research guidelines before purchasing or using this compound.

Frequently Asked Questions

Is GW 0742 Safe for Human Consumption?

No. The FDA has not approved GW 0742 for human or veterinary use. Purerawzus.com supplies this compound strictly for laboratory and scientific research purposes only.

Does GW 0742 Improve Glucose Metabolism in Research Models?

Animal study data has suggested that GW 0742 may improve glucose homeostasis in diabetic research models through PPAR-δ activation pathways. These findings remain under active scientific investigation and require further research to fully establish their broader implications.

How Does GW 0742 Differ From Cardarine in Research?

Both GW 0742 and Cardarine target the PPARβ/δ receptor and were originally developed by GlaxoSmithKline. The primary structural distinction is that GW 0742 contains two hydrogen and four fluorine atoms while Cardarine contains one hydrogen and three fluorine atoms, making GW 0742 a fluorinated analog of Cardarine with a distinct molecular research profile.

What Side Effects Have Been Observed With GW 0742?

As GW 0742 research remains primarily limited to animal and cell-based studies its complete side effect profile in broader research contexts has not yet been fully established. Human clinical research is currently limited. Researchers are encouraged to follow all applicable laboratory safety protocols when handling this compound.

Disclaimer

All information on this page is provided for educational purposes only and does not constitute medical or professional advice. Products are for laboratory and research use only. By ordering you agree to our Terms and Conditions. Contact us at sales@purerawzus.com for any concerns.

All products are for laboratory and research purposes only and are not intended for veterinary or human use.